Clinical Trial Update: MC-5A for Chemotherapy Induced Peripheral Neuropathy [Phase 2]

View source ↗

Summary

Phase 2 trial update for MC-5A addressing chemotherapy-induced peripheral neuropathy; study completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuropathy
• Paraneoplastic Neuropathy

Drugs mentioned

• MC-5A

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Neuropathy, Paraneoplastic | Phase 2 | Status: COMPLETED | Results posted: 2017-11-06